Genscript Biotech Corporation (FRA:G51)
1.625
-0.009 (-0.55%)
At close: Dec 5, 2025
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of €3.64 billion as of December 5, 2025. Its market cap has increased by 29.94% in one year.
Market Cap
3.64B
Enterprise Value
3.30B
Revenue
705.13M
Ranking
n/a
PE Ratio
1.37
Stock Price
€1.63
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 249.76M to 3.64B, an increase of 1,355.64%. That is a compound annual growth rate of 30.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |